Adelaide Research & Scholarship: Search

Search

Results 1-10 of 11 (Search time: 0.004 seconds).

previous
1
2
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2009	Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation	Degenhardt, L.; Larance, B.; Bell, J.; Winstock, A.; Lintzeris, N.; Ali, R.; Scheuer, N.; Mattick, R.
	2016	Diversion and injection of buprenorphine-naloxone film two years post-introduction in Australia	Larance, B.; Mattick, R.; Ali, R.; Lintzeris, N.; Jenkinson, R.; White, N.; Kihas, I.; Cassidy, R.; Degenhardt, L.; Wilkinson, C.; Livingston, M.
	2015	Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol	Degenhardt, L.; Larance, B.; Bruno, R.; Lintzeris, N.; Ali, R.; Farrell, M.
	2015	A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodone	Peacock, A.; Degenhardt, L.; Larance, B.; Cama, E.; Lintzeris, N.; Ali, R.; Bruno, R.
	2015	Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids	Peacock, A.; Bruno, R.; Cama, E.; Kihas, I.; Larance, B.; Lintzeris, N.; Hordern, A.; White, N.; Ali, R.; Degenhardt, L.
	2022	Examining the cost and impact of dosing fees among clients in opioid agonist treatment: results from a cross-sectional survey of Australian treatment clients	Zahra, E.; Chen, R.; Nielsen, S.; Tran, A.D.; Santo, T.; Degenhardt, L.; Farrell, M.; Byrne, J.; Ali, R.; Larance, B.
	2015	The characteristics of a cohort who tamper with prescribed and diverted opioid medications	Larance, B.; Lintzeris, N.; Bruno, R.; Peacock, A.; Cama, E.; Ali, R.; Kihas, I.; Hordern, A.; White, N.; Degenhardt, L.
	2016	The extramedical use and diversion of opioid substitution medications and other medications in prison settings in Australia following the introduction of buprenorphine-naloxone film	White, N.; Ali, R.; Larance, B.; Zador, D.; Mattick, R.P.; Degenhardt, L.
	2013	A randomised controlled trial of sublingual buprenorphine-naloxone film versus tablets in the management of opioid dependence	Lintzeris, N.; Leung, S.; Dunlop, A.; Larance, B.; White, N.; Rivas, G.; Holland, R.; Degenhardt, L.; Muhleisen, P.; Hurley, M.; Ali, R.
	2011	Post-marketing surveillance of buprenorphine-naloxone in Australia: Diversion, injection and adherence with supervised dosing	Larance, B.; Degenhardt, L.; Lintzeris, N.; Bell, J.; Winstock, A.; Dietze, P.; Mattick, R.; Ali, R.; Horyniak, D.